Use one dose, one form, and one goal for 8-12 weeks
Advances in nanotechnology for enhancing the solubility and bioavailability of poorly soluble drugs
To access a treatment through a compassionate use program, a physician and patient first have to agree it is the only option, as laid out by FDA regulations
If successful, RJVA-001 could transform how we think about [type 2 diabetes], from a chronic disease you manage every day to one that could potentially be treated once.
Rising global prevalence of obesity and type 2 diabetes is a primary growth driver for the market
But compounded with dehydration from vomiting, reduced food intake from extreme appetite suppression, and interaction with other diabetes medications, blood sugar can drop to dangerous levels